{"id":"https://openalex.org/W7204801432","doi":"https://doi.org/10.64898/2026.08.28.747865","title":"In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma","display_name":"In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma","publication_year":2026,"publication_date":"2026-08-31","ids":{"openalex":"https://openalex.org/W7204801432","doi":"https://doi.org/10.64898/2026.08.28.747865","pmid":"https://pubmed.ncbi.nlm.nih.gov/42922713","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13684626"},"language":"en","primary_location":{"id":"doi:10.64898/2026.08.28.747865","doi":"https://doi.org/10.64898/2026.08.28.747865","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.08.28.747865","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/08/31/2026.08.28.747865.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/08/31/2026.08.28.747865.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065603170","display_name":"Ritchie Delara","orcid":"https://orcid.org/0000-0002-2770-2155","observed_orcids":["https://orcid.org/0000-0002-2770-2155"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ritchie Delara","raw_affiliation_strings":["Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]},{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007215225","display_name":"Vaidehi Mujumdar","orcid":"https://orcid.org/0000-0001-5687-6667","observed_orcids":["https://orcid.org/0000-0001-5687-6667"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vaidehi Mujumdar","raw_affiliation_strings":["Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]},{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100360324","display_name":"Qi Zhang","orcid":"https://orcid.org/0000-0002-5824-2534","observed_orcids":["https://orcid.org/0000-0002-5824-2534"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]},{"id":"https://openalex.org/I4387930303","display_name":"Wake Forest Baptist Comprehensive Cancer Center","ror":"https://ror.org/0512csj88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I4387930303","https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Zhang","raw_affiliation_strings":["Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4387930303"]},{"raw_affiliation_string":"Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]},{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092083504","display_name":"Hailey L. Dryden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hailey Dryden","raw_affiliation_strings":["Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110063367","display_name":"Erin Crane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Crane","raw_affiliation_strings":["Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011323945","display_name":"Jubilee Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jubilee Brown","raw_affiliation_strings":["Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133867854","display_name":"Wendel Naumann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendel Naumann","raw_affiliation_strings":["Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062645580","display_name":"Allison M. Puechl","orcid":"https://orcid.org/0000-0003-0761-7727","observed_orcids":["https://orcid.org/0000-0003-0761-7727"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Puechl","raw_affiliation_strings":["Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051183306","display_name":"David Foureau","orcid":"https://orcid.org/0000-0003-4230-8356","observed_orcids":["https://orcid.org/0000-0003-4230-8356"]},"institutions":[{"id":"https://openalex.org/I4387930303","display_name":"Wake Forest Baptist Comprehensive Cancer Center","ror":"https://ror.org/0512csj88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I4387930303","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Foureau","raw_affiliation_strings":["Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","Levine Cancer Institute, Division of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4387930303"]},{"raw_affiliation_string":"Levine Cancer Institute, Division of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054726478","display_name":"Wei Sha","orcid":"https://orcid.org/0000-0003-4740-2325","observed_orcids":["https://orcid.org/0000-0003-4740-2325"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]},{"id":"https://openalex.org/I4387930303","display_name":"Wake Forest Baptist Comprehensive Cancer Center","ror":"https://ror.org/0512csj88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I4387930303","https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Sha","raw_affiliation_strings":["Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4387930303"]},{"raw_affiliation_string":"Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073517803","display_name":"Jessica Legrand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387930303","display_name":"Wake Forest Baptist Comprehensive Cancer Center","ror":"https://ror.org/0512csj88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I4387930303","https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica LeGrand","raw_affiliation_strings":["Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4387930303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053912961","display_name":"Hsih\u2010Te Yang","orcid":"https://orcid.org/0000-0002-4851-1374","observed_orcids":["https://orcid.org/0000-0002-4851-1374"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hsih Te Yang","raw_affiliation_strings":["Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084809356","display_name":"Karl J. Dykema","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl Dykema","raw_affiliation_strings":["Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092083505","display_name":"Bharath Yada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bharath Yada","raw_affiliation_strings":["Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029669507","display_name":"Cody C. McHale","orcid":"https://orcid.org/0000-0002-1242-2417","observed_orcids":["https://orcid.org/0000-0002-1242-2417"]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cody C. McHale","raw_affiliation_strings":["Levine Cancer Institute, Division of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Levine Cancer Institute, Division of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024846620","display_name":"Maddeboina Krishnaiah","orcid":"https://orcid.org/0009-0000-4385-9788","observed_orcids":["https://orcid.org/0009-0000-4385-9788"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]},{"id":"https://openalex.org/I4387930303","display_name":"Wake Forest Baptist Comprehensive Cancer Center","ror":"https://ror.org/0512csj88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I4387930303","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Krishnaiah Maddeboina","raw_affiliation_strings":["Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","Biologica LLC, Charlotte, NC","Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC","Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4387930303"]},{"raw_affiliation_string":"Biologica LLC, Charlotte, NC","institution_ids":[]},{"raw_affiliation_string":"Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067264614","display_name":"Dhananjaya Pal","orcid":"https://orcid.org/0000-0001-7675-4819","observed_orcids":["https://orcid.org/0000-0001-7675-4819"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dhananjaya Pal","raw_affiliation_strings":["Biologica LLC, Charlotte, NC","Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biologica LLC, Charlotte, NC","institution_ids":[]},{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025976004","display_name":"Donald L. Durden","orcid":"https://orcid.org/0000-0001-5386-1427","observed_orcids":["https://orcid.org/0000-0001-5386-1427"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]},{"id":"https://openalex.org/I4387930303","display_name":"Wake Forest Baptist Comprehensive Cancer Center","ror":"https://ror.org/0512csj88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I4387930303","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Donald L. Durden","raw_affiliation_strings":["Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","Biologica LLC, Charlotte, NC","Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC","Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4387930303"]},{"raw_affiliation_string":"Biologica LLC, Charlotte, NC","institution_ids":[]},{"raw_affiliation_string":"Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"raw_affiliation_string":"Molecular Targeted Therapeutics Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5024846620","https://openalex.org/A5025976004","https://openalex.org/A5067264614"],"corresponding_institution_ids":["https://openalex.org/I4210100342","https://openalex.org/I4387930303","https://openalex.org/I4405269449","https://openalex.org/I47251452"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.44040000438690186,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.44040000438690186,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.415800005197525,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.020899999886751175,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multitarget-directed-ligands","display_name":"multi-target-directed ligands","score":0.9710000157356262},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.7770000100135803},{"id":"https://openalex.org/keywords/endometrial-adenocarcinoma","display_name":"endometrial adenocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/cdk9-inhibition","display_name":"CDK9 inhibition","score":0.8809999823570251},{"id":"https://openalex.org/keywords/cdk4-6-inhibition","display_name":"CDK4/6 inhibition","score":0.8889999985694885},{"id":"https://openalex.org/keywords/transcriptional-addiction","display_name":"transcriptional addiction","score":0.9340000152587891},{"id":"https://openalex.org/keywords/nascent-rna","display_name":"nascent RNA","score":0.7630000114440918},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.6209999918937683},{"id":"https://openalex.org/keywords/transcription-elongation","display_name":"transcription elongation","score":0.7329999804496765},{"id":"https://openalex.org/keywords/computer-aided-drug-design","display_name":"computer-aided drug design","score":0.7409999966621399},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.9674000144004822},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.8726000189781189},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7202000021934509},{"id":"https://openalex.org/C105951970","wikidata":"https://www.wikidata.org/wiki/Q1036748","display_name":"Loss function","level":4,"score":0.6414999961853027},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.5199999809265137},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.4765999913215637},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4327000081539154},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.42890000343322754},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39629998803138733},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.3781999945640564},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.3691999912261963},{"id":"https://openalex.org/C179926584","wikidata":"https://www.wikidata.org/wiki/Q207714","display_name":"Transcription (linguistics)","level":2,"score":0.349700003862381},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3472999930381775},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3165999948978424},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.31619998812675476},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.29809999465942383},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2888000011444092},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2865000069141388},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.27639999985694885},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.26510000228881836},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.25200000405311584}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.64898/2026.08.28.747865","doi":"https://doi.org/10.64898/2026.08.28.747865","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.08.28.747865","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/08/31/2026.08.28.747865.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmid:42922713","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42922713","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"bioRxiv : the preprint server for biology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13684626","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13684626/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.64898/2026.08.28.747865","doi":"https://doi.org/10.64898/2026.08.28.747865","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.08.28.747865","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/08/31/2026.08.28.747865.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1983492565","display_name":"Role of  PTEN and PI-3 Kinase in  Medulloblastomagenesis","funder_award_id":"R01CA172513","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2577419345","display_name":null,"funder_award_id":"P30CA012197","funder_id":"https://openalex.org/F4320313862","funder_display_name":"Comprehensive Cancer Center at Wake Forest Baptist Medical Center"},{"id":"https://openalex.org/G8282494516","display_name":"Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer","funder_award_id":"R01CA215651","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000328302","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA012197","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320313862","display_name":"Comprehensive Cancer Center at Wake Forest Baptist Medical Center","ror":"https://ror.org/0512csj88"},{"id":"https://openalex.org/F4320317917","display_name":"Leon Levine Foundation","ror":"https://ror.org/05y2ktd97"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204801432.pdf","grobid_xml":"https://content.openalex.org/works/W7204801432.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1650807611","https://openalex.org/W1834739414","https://openalex.org/W1983704814","https://openalex.org/W1994139728","https://openalex.org/W1994551053","https://openalex.org/W1998038367","https://openalex.org/W2033801757","https://openalex.org/W2041440766","https://openalex.org/W2101117526","https://openalex.org/W2127587566","https://openalex.org/W2131776307","https://openalex.org/W2169964255","https://openalex.org/W2292874918","https://openalex.org/W2502676454","https://openalex.org/W2580664298","https://openalex.org/W2891127847","https://openalex.org/W2896872272","https://openalex.org/W2942313914","https://openalex.org/W2945071141","https://openalex.org/W2970432402","https://openalex.org/W2987340690","https://openalex.org/W3036382165","https://openalex.org/W3044329447","https://openalex.org/W3045386594","https://openalex.org/W3082285483","https://openalex.org/W3133865815","https://openalex.org/W3162631736","https://openalex.org/W4205424502","https://openalex.org/W4309473110","https://openalex.org/W4379057939","https://openalex.org/W4386505615","https://openalex.org/W4391264121","https://openalex.org/W4395468216","https://openalex.org/W4399379059","https://openalex.org/W4401528069","https://openalex.org/W4409540098","https://openalex.org/W4412980413","https://openalex.org/W4415980210","https://openalex.org/W7124243759","https://openalex.org/W7160513710"],"related_works":["https://openalex.org/W7148825446","https://openalex.org/W4399327709","https://openalex.org/W4393096359","https://openalex.org/W7148985061","https://openalex.org/W3024085365","https://openalex.org/W589946522","https://openalex.org/W2142747850","https://openalex.org/W2999871199","https://openalex.org/W2150798124","https://openalex.org/W2088269540"],"abstract_inverted_index":{"Abstract":[0],"To":[1,157],"combat":[2],"refractory":[3],"diseases,":[4],"such":[5],"as":[6],"cancer,":[7],"multitarget-directed":[8],"ligands":[9],"(MTDLs)":[10],"have":[11],"become":[12],"an":[13,187],"emerging":[14],"area":[15],"of":[16,35,41,48,56,62,103,145,155,194,221],"research":[17],"to":[18,70,74,106,142,148,191,227,238],"exploit":[19,158],"synthetic":[20],"lethality":[21],"(SL)":[22],"relationships":[23],"associated":[24,200],"with":[25,112],"drug":[26],"resistance.":[27],"Herein,":[28],"we":[29,163],"present":[30],"the":[31,38,60,167,213,216,222,242,254],"in":[32,52,82,85,93,115,122,132,164,182,218,234,239,249],"silico":[33,165,219],"design":[34,220],"MTDLs":[36],"for":[37,215],"polypharmaceutical":[39],"treatment":[40],"endometrial":[42],"adenocarcinoma":[43],"(EAC)":[44],"and":[45,59,89,108,128,140,150,198,247],"our":[46],"discovery":[47],"a":[49,90,96,100,116,159],"novel":[50,160],"SL":[51],"EAC;":[53],"PTEN":[54,80,133,136,183,192,235],"loss":[55,193],"function":[57],"(LOF)":[58],"inhibition":[61,197],"CDK9.":[63],"We":[64],"used":[65],"high-resolution":[66],"x-ray":[67],"crystallographic":[68],"data":[69],"chemically":[71],"engineer,":[72],"LCI133,":[73],"inhibit":[75],"CDK9,":[76],"CDK4/6-and":[77],"AURKA/B":[78],"kinases.":[79],"LOF":[81,134,137,184],"EAC":[83,146,185,237],"results":[84,114],"augmented":[86],"deregulated":[87],"transcription":[88,245],"massive":[91],"increase":[92],"nascent":[94],"RNA,":[95],"phenotype":[97],"which":[98,176],"encodes":[99],"high":[101],"level":[102],"apoptotic":[104],"sensitivity":[105,144],"LCI133":[107,113,149,175,226],"CDK9":[109,152,196],"inhibitors.":[110,153],"Treatment":[111],"rapid":[117],"decline":[118],"\u201c":[119],"nose-dive":[120],"\u201d":[121],"global":[123],"nRNA,":[124],"MYC":[125],"nRNA":[126],"levels":[127],"TS":[129,202],"elongation":[130,203],"(TE)":[131],"EAC.":[135],"is":[138],"necessary":[139],"sufficient":[141],"confer":[143],"cells":[147],"other":[151],"Statement":[154],"significance":[156],"pharmacologic":[161],"SL,":[162],"engineered":[166],"highly":[168],"selective":[169,230],"triple-action":[170],"small":[171],"molecule":[172],"CDK9-CDK4/6-AURKA/B":[173],"inhibitor,":[174],"induces":[177],"cancer":[178,251],"cell":[179,243,252],"death":[180],"selectively":[181],"cells,":[186],"effect":[188],"causally":[189],"linked":[190],"function,":[195],"its":[199],"deregulated/augmented":[201],"phenotype,":[204],"transcriptional":[205],"addiction":[206],"(TA).":[207],"Graphical":[208],"abstract":[209],"Schematic":[210],"diagram":[211],"shows":[212],"rationale":[214],"intentional":[217],"triple":[223],"inhibitory":[224],"chemotype,":[225],"block":[228],"three":[229],"clinically":[231],"relevant":[232],"targets":[233],"mutated":[236],"vivo":[240],"perturb":[241],"cycle,":[244],"(TS)":[246],"mitosis":[248],"same":[250,255],"at":[253],"time":[256],"(SL).":[257]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-09-01T00:00:00"}